Anaptysbio (ANAB) EBT Margin (2016 - 2026)
Anaptysbio (ANAB) reported EBT Margin of 206.78% for Q1 2026, down 6532.0% on a YoY basis from 3.21% in Q1 2025, and down 347.09% quarter-over-quarter from 83.68% in Q4 2025.
Anaptysbio (ANAB) EBT Margin (2016 - 2026) Analysis & Trends
Anaptysbio has reported EBT Margin for 11 years, with the latest figure at 206.78% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 6532.0% year-over-year to 206.78%; the trailing twelve-month figure through Mar 2026 stood at 7.85% (up 17086.0% YoY), and the FY2024 full-year result was 159.25%, down 15900.0% from the prior year.
- EBT Margin for Q1 2026 stood at 206.78%, down from 83.68% in the prior quarter.
- The five-year high for EBT Margin was 1347.75% in Q4 2023, with the low at 3237.84% in Q1 2022.
- Historically, EBT Margin has averaged 798.67% across 5 years, with a median of 425.22% in 2024.
- The largest YoY upside for EBT Margin was 263239 bps in 2022 against a maximum downside of 305618 bps in 2022.
- Anaptysbio's EBT Margin stood at 442.68% in 2022, then jumped by 404 bps to 1347.75% in 2023, then tumbled by 107 bps to 87.72% in 2024, then soared by 195 bps to 83.68% in 2025, then plunged by 347 bps to 206.78% in 2026.
- The last three EBT Margin figures came in at 206.78% (Q1 2026), 83.68% (Q4 2025), and 30.23% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -206.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.78% |
| Dec 31, 2025 | 83.68% |
| Sep 30, 2025 | 30.23% |
| Jun 30, 2025 | -173.34% |
| Mar 31, 2025 | -141.46% |
| Dec 31, 2024 | -87.72% |
| Sep 30, 2024 | -219.01% |
| Jun 30, 2024 | -425.22% |
| Mar 31, 2024 | -612.01% |
| Dec 31, 2023 | 1,347.75% |
| Sep 30, 2023 | -1,124.41% |
| Jun 30, 2023 | -1,151.59% |
| Mar 31, 2023 | -2,905.02% |
| Dec 31, 2022 | -442.68% |
| Sep 30, 2022 | -2,116.86% |
| Jun 30, 2022 | -2,195.07% |
| Mar 31, 2022 | -3,237.84% |
| Dec 31, 2021 | -3,075.07% |
| Sep 30, 2021 | -33.50% |
| Jun 30, 2021 | -2.15% |